Frequent Quantitation of Circulating Tumor Cells Predictive of Real-Time Therapy Response
Lim, C. M.; Shi, J.; Vo, J.; Phyo, W. M.; Hu, M.; Tan, M. C.; Tee, A.; Yap, Y. S.; Nei, W.; Chan, D.; Wong, S. W.; Neo, M.; Binte Mohammad Mazian, N.; Ying, J. Y.; Tan, M.-H.; Liang, K.; Mong, J.
Show abstract
Precision medicine is playing an increasingly important role in cancer management and treatment. Specifically in the field of oncology, circulating tumor cells (CTCs) hold significant promise in enabling non-invasive prognostication and near real-time monitoring to individualize treatments. In this study, we present strong associations between CTC subtype counts with treatment response and tumor staging in lung, nasopharyngeal and breast cancers. Longitudinal analysis of CTC count changes over short-time windows further reveals the ability to predict treatment response close to real-time. Our findings demonstrate the suitability of CTCs as a definitive blood-based metric for continuous treatment monitoring. Robust processing of high-throughput image data, explainable classification of CTC subtypes and accurate quantification were achieved using an in-house image analysis system CTC-Quant, which showed excellent agreement with expert opinion upon extensive validation.
Matching journals
The top 5 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Use of high-plex data reveals novel insights into the tumour microenvironment of clear cell renal cell carcinoma 95%
- Identification of atypical circulating tumor cells with prognostic value in metastatic breast cancer patients 94%
- Accurate Screening for Early-Stage Breast Cancer by Detection and Profiling of Circulating Tumor Cells 94%
Similar papers in this journal
- Extracellular vesicle molecular signatures characterize metastatic dynamicity in ovarian cancer 95%
- Circulating tumor fraction analyses with ultra-low pass whole genome sequencing predict response to chemoradiation and recurrence in stage IV small cell carcinoma of the cervix: a longitudinal case study 94%
- Syngeneic model of carcinogen-induced tumor mimics basal/squamous, stromal-rich, and neuroendocrine molecular and immunological features of muscle-invasive bladder cancer 94%
Similar papers in this journal
- Non-B DNA-Informed Mutation Burden as a Marker of Treatment Response and Outcome in Cancer 92%
- A prospective validation of nomograms based on BC-116 and BC-106 urine peptide biomarker panels for bladder cancer diagnostics and monitoring 92%
- Frequent post-treatment monitoring of colorectal cancer using individualized ctDNA validated by multi-regional molecular profiling 92%
Similar papers in this journal
- Predicting Oncogene Mutations of Lung Cancer Using Deep Learning and Histopathologic Features on Whole-Slide Images 95%
- Clinical Significance of Circulating Tumor Cells in Unresectable Pancreatic Ductal Adenocarcinomas 94%
- Gene expression profiles of inflammatory breast cancer reveal high heterogeneity across the epithelial-hybrid-mesenchymal spectrum 93%
Similar papers in this journal
- Image-Based Consensus Molecular Subtyping in Rectal Cancer Biopsies and Response to Neoadjuvant Chemoradiotherapy 93%
- Cancer drug sensitivity prediction from routine histology images 92%
- Explainable, federated deep learning model predicts disease progression risk of cutaneous squamous cell carcinoma 92%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.